HHLR ADVISORS, LTD. - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$350,739,000
+0.3%
2,962,0760.0%3.47%
+24.6%
Q4 2020$349,851,000
+6.3%
2,962,0760.0%2.78%
+11.5%
Q3 2020$329,205,000
+8.8%
2,962,0760.0%2.49%
-9.9%
Q2 2020$302,665,000
+1.9%
2,962,076
+7.7%
2.77%
-30.9%
Q1 2020$296,937,000
-7.3%
2,751,2000.0%4.00%
+0.3%
Q4 2019$320,185,000
+1.7%
2,751,2000.0%3.99%
-7.9%
Q3 2019$314,930,000
+20.1%
2,751,2000.0%4.33%
-26.2%
Q2 2019$262,189,000
+4.4%
2,751,2000.0%5.86%
-16.2%
Q1 2019$251,047,000
+20.2%
2,751,2000.0%6.99%
-19.3%
Q4 2018$208,844,0002,751,2008.66%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders